The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays

Blood

Volumn 101, Issue 11, 2003, Pages 4598-4606

  Vallat, Laurent ^b   Magdelénat, Henri ^b   Merle Béral, Hélène ^b   Masdehors, Peggy ^b   De Montalk, Gabrielle Potocki ^b   Davi, Frédéric ^b   Kruhoffer, Mogens ^b   Sabatier, Laure ^b   Orntoft, Torben F ^b   Delic, Jozo ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 27; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MOLECULAR MARKER; PROTEIN; PROTEIN BLK; PROTEIN ECH 1; PROTEIN FMOD; PROTEIN GOS 19 1; PROTEIN MAT 2A; STAT1 PROTEIN; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG; PROTEIN P53; TUMOR MARKER;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL SPECIFICITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DNA DAMAGE; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; INTERMETHOD COMPARISON; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE SIZE; UNINDEXED SEQUENCE; UPREGULATION; B CELL LEUKEMIA; GENE EXPRESSION REGULATION; GENETICS; LYMPHOCYTE SUBPOPULATION; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; RADIATION EXPOSURE;

APOPTOSIS; DNA DAMAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LYMPHOCYTE SUBSETS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0038481230     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-06-1743     Document Type: Article

References (47)

1. Caligaris-Cappio F. Biology of chronic lymphocytic leukemia. Rev Clin Exp Hematol, 2000;4:5-21.
2. Hanada M, Delia D, Aiello A, Stedtmauer E, Reed JC. Bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia. Blood. 1993;82:1820-1828.
3. Stankovic T, Weber P, Stewart G, et al. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukemia. Lancet. 1999; 353:26-29.
4. Bulrich F, Rasio D, Kitada S, et al. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res. 1999;59:24-27.
5. Starostik P, Manshouri T, O'Brien S, et al. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res. 1998;58:4552-4557.
6. Pettitt AR, Sherington PD, Stewart G, Cawley JC, Taylor AM, Stankovic T. p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood. 2001; 98:814-822.
7. Masdehors P, Merle-Béral H, Maloum K, Omura S, Magdelenat H, Delic J. Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes. Blood. 2000;96:269-274.
8. Hershko A, Ciechanover A. The ubiquitin system. Ann Rev Biochem. 1998;67: 425-479.
9. Delic J, Morange M, Magdelenat H. Ubiquitin pathway involvement in human lymphocytes γ-irradiation-induced apoptosis. Mol Cell Biol, 1993;13:4875-4883.
10. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med, 2001;194:1625-1638.
11. Rosenwald A, Alizadeh AA, Widhopf G, et al. Regulation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194: 1639-1647.
12. Stratowa C, Löeffler G, Lichter P, et al. CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer. 2001;91:474-480.
13. Duggan D, Bittner M, Chen Y, Meltzer P, Trent JM. Expression profiling using cDNA microarray. Nat Genet. 1999;21:10-14.
14. Southern E, Mir K, Shchepinov M. Molecular interactions on microarrays Nat Genet., 1999;21: 5-9.
15. Cho RJ, Fromont-Racine M, Wodicka L, et al Parallel analysis of genetic selections using whole genome oligonucleofide arrays. Proc Natl Acad Sci U S A. 1998;95:3752-3757.
16. Planet PJ, DeSalle R, Siddall M, Bael T, Neil Sarkar I, Stanley SE. Systematic analysis of DNA microarray data: ordering and interpreting patterns of gene expression. Genome Res. 2001;11: 1149-1155.
17. Knight J. When chips are down. Nature. 2000; 410:860-861.
18. Stoppa-Lyonnet D, Alapetite C, Merle-Béral H, et al. Chromosomal DNA and p53 stability, ubiquitin system and apoptosis in B-CLL lymphocytes. Leuk Lymphoma. 2001;42:1173-1180.
19. Amundson SA, Bittner M, Chen Y, Trent J, Meltzer P, Fornace AJ Jr. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses Oncogene. 1999;18:3666-3672.
20. Alon U, Barkai N, Notterman, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide array. Proc Natl Acad Sci U S A. 1999;96:6745-6750.
21. Voehringer DW, Hirschberg DL, Xiao J, et al. Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc Natl Acad Sci U S A. 2000;97:2680-2685.
22. Zhao R, Gish K, Murphy M, et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 2000;14:981-993.
23. Kannan K, Amarigllo N, Rechavi G, et al. DNA microarray identification of primary and secondary target genes regulated by p53. Oncogene, 2001;20:2225-2234.
24. Hofmann W-K,de Vos S, Tsukasaki K, et al. Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood. 2001;98:787-794.
25. Blaise R, Alapetite C, Masdehors P, et al. High level of chromosome aberrations correlate with impaired in vitro radiation-induced apoptosis and DNA repair in human B-chronic lymphocytic leukaemia cells. Int J Radiat Biol. 78:671-679.
26. Sellins KS, Cohen JJ. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol. 1987;139:3199-3205.
27. Li H, Kumar Kolluri S, Gu J, et al. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science. 2000;289:1159-1164.
28. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992;69:119-128.
29. Fanidi A, Harrington EA, Evan GI. Cooperative interacton between c-myc and bcl-2 proto-oncogenes. Nature. 1992;359:554-556.
30. Eischen CM, Woo D, Roussel MF, Cleveland JL. Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol Cell Biol. 2001;21:5063-5070.
31. Owyang AM, Tumang JR, Schram BR, et al. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis. J Immunol. 2001;167:4948-4956.
32. Klefstrom J, Arighi E, Littlewood T, et al. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-κB activation. EMBO J. 1997;16:7382-7392.
33. Yang H, Huang Z-Z, Zeng Z, Chen C, Selby RR, Lu SC. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer. Am J Physiol Gastrointest Liver Physiol. 2001;280:G184-G190.
34. Spector NL, Hardy L, Ryan C, et al. 28-kDa mammalian heat shock protein, a novel substrate of a growth regulatory protease involved in differentiation of human leukemia cells. J Biol Chem. 1995; 270:1003-1006.
35. Coffer PJ, Koenderman L, Groot RP. The role of STATs in myeloid differentiation and leukemia. Oncogene. 2000;15:2511-2522.
36. Williams JG. STAT signalling in cell proliferation and in development. Curr Opin Genet Dev. 2000; 10:503-507.
37. Blum S, Forsdyke RE, Forsdyke DR. Three human homologs of a murine gene encoding an inhibitor of stem cell proliferation. DNA Cell Biol. 1990;9:589-602.
38. Hsueh RC, Scheuermann RH. Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor. Adv Immunol. 2000;75: 283-316.
39. Malek SN, Dordai DI, Reim J, Dintzis H, Desiderio S. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. Proc Natl Acad Sci U S A. 1998; 95:7351-7356.
40. Labelle Y, Bussieres J, Courjal F, Goldring MB. The EWS/TEC fusion protein encoded by the t(9; 22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator. Oncogene. 1999;27:3303-3308.
41. Still IH, Chernova O, Hurd D, Stone RM, Cowell JK. Molecular characterization of the t(8;13) (p11; q12) translocation associated with an atypical myeloproliferative disorder: evidence for three discrete loci involved in myeloid leukemias on 8p11. Blood. 1997;90:3136-3141.
42. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci U S A. 1996;93:4974-4978.
43. Oldenberg A, Antonsson P, Lindblom K, Heinegard D. A collagen-binding 59-kd protein (fibromodulin) is structurally related to the small interstitial proteoglycans PG-S1 and PG-S2 (decorin). EMBO J. 1989;8:2601-2604.
44. Iozzo RV. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem. 1999;274:18843-18846.
45. Yamaguchi Y, Mann DM, Ruoslahti E. Negatlve regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990;346:281-284.
46. Santra M, Eichstetter I, Iozzo RV. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem. 2000;275:35153-35161.
47. Ling X, Kamangar S, Boytim ML, et al. Proliferating cell nuclear antigen as the cell cycle sensor for an HLA-derived peptide blocking T cell proliferation. J Immunol. 2000;164:6188-6192.